For instance, studies have shown that ASNS inhibition combined with L-ASNase enhances cell cycle arrest and apoptosis in certain resistant tumors like melanoma, epidermoid carcinoma, triple-negative breast cancer, KRAS-mutant colorectal and lung cancers, ovarian cancer, supporting its role as a therapeutic target (142). The gene discussed is ASNS; the disease is melanoma.